Phase IIb trial of ispronicline in adults with attention-deficit hyperactivity disorder.

Trial Profile

Phase IIb trial of ispronicline in adults with attention-deficit hyperactivity disorder.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Dec 2011

At a glance

  • Drugs Ispronicline (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Oct 2010 Planned initiation date changed from 1 Jun 2010 to 1 Mar 2011.
    • 12 Feb 2010 Initiation is expected in mid 2010, according to a Targacept media release.
    • 13 Jul 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top